Ju­lian Adams man­ages to com­plete his $50M IPO at Gami­da Cell — at a heavy cost

Ju­lian Adams has his $50 mil­lion IPO, but it cost plen­ty.

The Gami­da Cell CEO, who’s steer­ing his way through a late-stage study with a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA